300430120485

NOVARTIS CONSUMER HEALTH, INC. 48 count Tavist D Allergy/Sinus/Headache

AI Insights

The barcode 300430120485 is associated with "Tavist D Allergy/Sinus/Headache," produced by Novartis Consumer Health, Inc. This product is an over-the-counter (OTC) medication specifically designed to alleviate symptoms related to allergies, sinus congestion, and headaches.

Tavist D contains two active ingredients:

  1. Diphenhydramine - an antihistamine that helps relieve allergy symptoms.
  2. Phenylephrine - a decongestant that helps reduce nasal congestion.

Health-Related Warnings:

  • Dosage Limitation: Do not exceed 3 doses in a 24-hour period.
  • Age Restriction: Consult a doctor before giving this medication to children under 6 years old.
  • Drug Interactions: Use caution when taking Tavist D with other medications that also contain diphenhydramine or phenylephrine.
  • Side Effects: This medication may cause drowsiness, dry mouth, and stomach upset. If these symptoms occur, taking an antacid or an H2 blocker may alleviate discomfort.

There are no specific warnings related to the 48-count packaging. However, as a general rule, OTC medications should be used as directed to minimize the risk of side effects.

Pricing:

Prices for Tavist D can vary based on location and retailer. Generally, a 24- or 30-count package ranges from $8 to $15 USD, while a larger 48-count package may cost between $12 and $25 USD.

In summary, Tavist D is an OTC medication aimed at relieving allergy, sinus, and headache symptoms, with specific warnings regarding its usage and potential side effects. Pricing can vary based on several factors.

Barcode Details
Source:
Producer Code:
Product Code:
Search Statistics
Today:
1
Last Week:
8
Last Month:
35
Total Searches:
210

Comments 0

No comments yet. Be the first to share your thoughts!

Customer Satisfaction

Was this product information useful?

0 / 0

Do you recommend this product?

0 / 0
Top 10 Countries
Vietnam 6
Unknown 20
United States 96
United Kingdom 8
United Arab Emirates 1
Singapore 19
Norway 1
Hong Kong 3
Germany 9
France 18
Finland 15
China 3
Canada 10
Brazil 1